- Home
- HRMY vs JBLU Comparison
HRMY vs JBLU Comparison
Compare HRMY & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- JBLU
- Stock Information
- Founded
- HRMY 2017
- JBLU 1998
- Country
- HRMY United States
- JBLU United States
- Employees
- HRMY N/A
- JBLU N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- JBLU Air Freight/Delivery Services
- Sector
- HRMY Health Care
- JBLU Consumer Discretionary
- Exchange
- HRMY Nasdaq
- JBLU Nasdaq
- Market Cap
- HRMY 1.9B
- JBLU 2.0B
- IPO Year
- HRMY 2020
- JBLU N/A
- Fundamental
- Price
- HRMY $26.11
- JBLU $4.71
- Analyst Decision
- HRMY Strong Buy
- JBLU Sell
- Analyst Count
- HRMY 10
- JBLU 9
- Target Price
- HRMY $50.80
- JBLU $5.11
- AVG Volume (30 Days)
- HRMY 1.0M
- JBLU 20.0M
- Earning Date
- HRMY 10-28-2025
- JBLU 10-28-2025
- Dividend Yield
- HRMY N/A
- JBLU N/A
- EPS Growth
- HRMY 58.41
- JBLU N/A
- EPS
- HRMY 3.10
- JBLU N/A
- Revenue
- HRMY $772,527,000.00
- JBLU $9,138,000,000.00
- Revenue This Year
- HRMY $19.94
- JBLU N/A
- Revenue Next Year
- HRMY $16.65
- JBLU $6.77
- P/E Ratio
- HRMY $8.37
- JBLU N/A
- Revenue Growth
- HRMY 17.74
- JBLU N/A
- 52 Week Low
- HRMY $25.58
- JBLU $3.34
- 52 Week High
- HRMY $41.61
- JBLU $8.31
- Technical
- Relative Strength Index (RSI)
- HRMY 30.89
- JBLU 45.24
- Support Level
- HRMY $25.95
- JBLU $4.43
- Resistance Level
- HRMY $26.97
- JBLU $4.94
- Average True Range (ATR)
- HRMY 0.79
- JBLU 0.24
- MACD
- HRMY 0.19
- JBLU 0.00
- Stochastic Oscillator
- HRMY 26.11
- JBLU 48.36
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.